Srinivas Raghavan Viswanathan

Dana-Farber Cancer Institute

NIH Rank #8911
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.5M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#8,911
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.5M across 3 grants · National rank #8911.

Top grants by award amount

Srinivas Raghavan Viswanathan's NIH grant portfolio, ranked by award amount.

  • 5R01CA286652-02R01
    Probing the role of somatic X-chromosome alterations in shaping cancer sex differences
    $519.2K
    award amount
  • 5R01CA269505-02R01
    Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
    $486.5K
    award amount
  • 5R01CA279044-02R01
    Molecular mechanisms and therapeutic targeting of activated NRF2 signaling in MiT/TFE translocation renal cell carcinoma
    $465K
    award amount

Affiliation

Institutions that have administered grants for Srinivas Raghavan Viswanathan.

Affiliated with Dana-Farber Cancer Institute (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Dana-Farber Cancer Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #8911